- SEK18.85bn
- SEK40.35bn
- SEK3.67bn
- 92
- 33
- 66
- 73
Annual income statement for Nyfosa AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,035 | 2,459 | 3,151 | 3,553 | 3,670 |
| Cost of Revenue | |||||
| Gross Profit | 1,415 | 1,650 | 2,091 | 2,444 | 2,541 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 379 | 50 | 534 | 1,296 | 1,089 |
| Operating Profit | 1,656 | 2,409 | 2,617 | 2,257 | 2,581 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2,399 | 3,644 | 1,859 | -661 | 253 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2,225 | 3,112 | 1,693 | -639 | 112 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 2,225 | 3,112 | 1,688 | -638 | 113 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2,225 | 3,112 | 1,689 | -701 | 56 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 12.2 | 16.6 | 8.84 | -3.67 | 0.277 |
| Dividends per Share |